Ropes & Gray advised Erasca, Inc. on the deal. Erasca, Inc. (Nasdaq: ERAS), a precision oncology company, announced it has entered into an exclusive license agreement...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here